Medical Condition News

RSS

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for breast cancer patients when diagnostic dilemmas arise.

29 Sep 2021

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

The Patient-Centered Outcomes Research Institute Board of Governors today approved $61.3 million for a slate of several infrastructure projects that will support the activities of eight Clinical Research Networks to implement the next phase of PCORnet, the National Patient-Centered Clinical Research Network.

29 Sep 2021

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Buck Institute professors Judith Campisi, PhD and Lisa Ellerby PhD, have been awarded a $14.3 million grant from the NIH's National Institute of Aging to study cellular senescence, one of the major hallmarks of aging, as a driver of Alzheimer's disease and other age-related dementias.

29 Sep 2021

Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate

Patients with excited delirium who are combative, aggressive or agitated before being transported to the hospital or in an emergency department setting require immediate treatment for their safety and others.

29 Sep 2021

Understanding noise-related hearing loss through changes in RNA levels

A growing number of people are suffering from hearing loss due to exposure to loud noises from heavy machinery, concerts, or explosions.

29 Sep 2021

Long-held theory of cancer-induced immune suppression requires revision, study says

Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism operates requires revision, according to a study published in Clinical Cancer Research.

29 Sep 2021

People with asymmetric brain arteries have a higher risk of developing aneurysms

It's called a silent killer. Warnings are rare, but of the million people who suffer a ruptured brain aneurysm each year, almost half will die and only a third will recover without disabilities.

29 Sep 2021

Study finds decline in referrals and procedures for common cardiac interventions after COVID-19

An analysis of healthcare data in Ontario, Canada found a significant decline in referrals and procedures performed for common cardiac interventions after the onset of the COVID-19 pandemic.

29 Sep 2021

Scientists link insulin resistance to increased risk of developing major depressive disorder

Stanford Medicine scientists have linked insulin resistance to an increased risk of developing a major depressive disorder.

29 Sep 2021

Bipolar disorder patients experiencing manic episodes likely to show abnormal brain changes

Patients with bipolar disorder who experience manic episodes are more likely to show abnormal brain changes over time, according to one of the largest longitudinal brain imaging studies in its field to date.

29 Sep 2021

Artificial intelligence tool to predict the risk of psychotic illness

One-third of children with a microdeletion of chromosome 22 will later develop a psychotic illness such as schizophrenia. But how do we know which of these children might be affected? Today, various studies have contributed to the understanding of the neurobiological mechanisms that are associated with the development of psychotic illnesses.

29 Sep 2021

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.

29 Sep 2021

Researchers explore the clinical use of intravenous infusions of ketamine to treat depression

Depression is the most common mental illness as well as the number one cause of disability among people between the ages of 15 and 44. And for millions of sufferers, antidepressants have literally saved lives that could otherwise have been lost to suicide.

29 Sep 2021

Heart healthy adults have lower lifetime risk of type 2 diabetes

Heart healthy middle-aged adults are less likely to develop type 2 diabetes during their lifetime, according to a study published on World Heart Day in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology.

29 Sep 2021

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Oncotarget published "Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma" which reported that Multiple Myeloma patients suffer disease relapse due to the development of therapeutic resistance. Increasing evidence suggests that immunotherapeutic strategies can provide durable responses.

29 Sep 2021

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

Chances are, the COVID-19 pandemic has affected your health — even if you have never been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to new research from Harvard Medical School, the stress of isolation from lockdown and stay-at-home measures is making people sick.

29 Sep 2021

Combination of two drugs may help pancreatic and liver cancer patients

A drug candidate discovered and developed decades ago in the laboratory of UC Davis distinguished professor Bruce Hammock may help control the body's raging and often deadly inflammatory response to chemotherapy treatments, especially for pancreatic and liver cancer patients.

29 Sep 2021

AIHW report: 1.2 million Australian adults affected by heart, stroke or vascular disease

A new report from the Australian Institute of Health and Welfare shows that 1.2 million Australian adults had one or more conditions related to heart, stroke or vascular disease in 2017–18.

29 Sep 2021

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

A new research study at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death.

29 Sep 2021

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

Alzheimer's is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia.

28 Sep 2021

Medical Condition News

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate

Understanding noise-related hearing loss through changes in RNA levels

Long-held theory of cancer-induced immune suppression requires revision, study says

People with asymmetric brain arteries have a higher risk of developing aneurysms

Study finds decline in referrals and procedures for common cardiac interventions after COVID-19

Scientists link insulin resistance to increased risk of developing major depressive disorder

Bipolar disorder patients experiencing manic episodes likely to show abnormal brain changes

Artificial intelligence tool to predict the risk of psychotic illness

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

Researchers explore the clinical use of intravenous infusions of ketamine to treat depression

Heart healthy adults have lower lifetime risk of type 2 diabetes

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

Combination of two drugs may help pancreatic and liver cancer patients

AIHW report: 1.2 million Australian adults affected by heart, stroke or vascular disease

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News